The largest database of trusted experimental protocols

4 protocols using anti cd68 fitc

1

Flow Cytometry Analysis of Primary Human Hepatocytes

Check if the same lab product or an alternative is used in the 5 most similar protocols
PHH were thawed, washed once with PBS and immediately fixed with 4% paraformaldehyde for 30 minutes on ice. After fixation, the cells were pelleted and blocked for 30 minutes on ice in PBS supplemented with 5% normal goat serum, 5% normal rabbit serum and 0.1% BSA for staining of cell-surface markers, or according to the manufacturer’s instructions for the eBioscience Intracellular Staining Kit (eBioscience, San Diego, CA) when detecting intracellular antigens. Next, cells were incubated with anti-CD45-FITC, anti-CD81-APC or anti-CD68-FITC (all BD Biosciences, San Jose, CA), anti-HLA-DR-FITC or anti-CD299-APC (both eBioscience), anti-human albumin-FITC (Rockland, Limerick, PA) or isotype-matched controls for 60 minutes on ice. All antibodies were used at manufacturer recommended concentrations except for anti-human albumin-FITC, which was used at 10 μg/mL. After staining, PHH were washed three times with PBS before being assessed by flow cytometry using a Fortessa LSR instrument (BD Biosciences). All flow cytometry data was analyzed using FlowJo V10.08r1 software (TreeStar Inc., Ashland, OR). A detailed description of all antibodies used is provided in S6 Table.
+ Open protocol
+ Expand
2

Phenotyping of BM Myeloid Cells in MM

Check if the same lab product or an alternative is used in the 5 most similar protocols
Collected 200 μl BM specimens from MM patients and HC, respectively. Subsequently, labeling the specimens with anti‐CD138‐Bv421, anti‐CD38‐APC, anti‐CSF1‐APC, anti‐CD14‐PerCP, anti‐CD68‐FITC, and anti‐CSF1R‐Bv421 antibodies was done (BD Biosciences). Among these, CD68 is an intracellular marker. The marker of intracellular staining was fixed and permeated with IntraSure Kit (BD Biosciences). Eventually, the data of CSF1 and CSF1R were acquired by flow cytometry (FCM) (Beckman CytoFLEX).
+ Open protocol
+ Expand
3

Multiparametric Flow Cytometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
EWS cell lines, human macrophages (M0, M1, and M2-like) and hBM-MSCs were analyzed by flow cytometry (FACSCanto II cytometer; Becton Dickinson) using the following antibodies: anti-CD99-FITC (3B2/TA8)(# 11–0997–42, eBioscience, RRID:AB_2016685), anti-CD14-FITC (#F0844, Dako), anti-CD68-FITC (#562117, BD Pharmingen), anti-CD80-PE (#5572227, BD), anti-CD86-FITC (#374204, BioLegend), anti-CD163-PE/Cy7(#25–1639–4, Affymetrix), anti-CD206-APC (#561763, BD), anti-CD47-PE (REA 220)(#130–123–754, Miltenyi Biotech, RRID:AB_2819520), and anti-calreticulin-PE (EPR3924) (LSC105731, LSBio-Life Span, RRID:AB_2069806). Detection and quantification of PS-positive cells was performed by flow cytometric analysis of annexin-V-FITC/PI-labeled cells (MEBCYTO Apoptosis Kit #4700, Medical & Biological Laboratories). Data are expressed as % positive cells or median fluorescence intensity (MFI). Flow samples were properly analyzed using FCS Express 7.18.0025 software (RRID:SCR_016431).
+ Open protocol
+ Expand
4

Immunophenotyping of MM Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Collected 200 μl BM specimens from MM patients and HC, respectively. Subsequently, labeling the specimens with anti‐CD3‐PerCP, anti‐CD8‐FITC, and anti‐PD‐1‐PE antibodies. Meanwhile, another group was labeled with anti‐CD14‐PerCP, anti‐CD68‐FITC, anti‐CD163‐PE, and anti‐CD200R‐APC and anti‐PD‐L1 antibodies (BD Biosciences). Eventually, the expression of PD‐1 on CD8 + T cells and PD‐L1 on TAMs was detected by flow cytometry (FCM) (Beckman CytoFLEX), and the data were analyzed by Cell QuestTMPro 4.0.2 software.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!